Shanghai OPM Biosciences Co Ltd. Stock Analysis 688293.SS

Shanghai OPM Biosciences Co. Ltd. engages in the cell culture products and services. The firm's main business involves two application areas: cell culture medium series products and biopharmaceutical contract development and production services. The firm's cell culture medium series products are widely used in the production of biological products such as protein/antibody production, vaccine production, cell therapy/gene therapy, and others. The firm's antibody drug development contract development and manufacturing organization (CDMO) service platform is committed to providing domestic and foreign customers with full-process services from antibody engineering humanization screening, cell line construction, process development to pilot production and clinical I&II phase sample production. The firm operates in both domestic and foreign markets.